Literature DB >> 23882436

Systematic Study of Structured Diagnostic Procedures in Outpatient Psychiatric Rehabilitation: A Three-year, Three-cohort Study of the Stability of Psychiatric Diagnoses.

Raymond Kotwicki1, Philip D Harvey.   

Abstract

Background. Psychiatric diagnoses are important for treatment planning. There are a number of current challenges in the area of psychiatric diagnosis with important treatment implications. In this study, we examined the differential usefulness of two semi-structured interviews of differing length compared to clinical diagnoses for generation of diagnoses that did not require modification over the course of treatment. Methods. We performed a three-year, three-cohort study at an outpatient psychiatric rehabilitation facility, comparing the stability of admission diagnoses when generated by unstructured procedures relying on referring clinician diagnosis, the SCID, and the MINI. We examined changes in diagnoses from admission to discharge (averaging 13 weeks) and, during the second two years, convergence between referring clinician diagnoses and those generated by structured interviews. The same three interviewers examined all patients in all three phases of the study. Results. Admission and discharge diagnoses were available for 313 cases. Diagnoses generated with the unstructured procedure were changed by discharge 74 percent of the time, compared to four percent for SCID diagnoses and 11 percent for MINI diagnoses. Referring clinician diagnoses were disconfirmed in Years 2 and 3 in 56 percent of SCID cases and 44 percent of MINI cases. The distinctions between unipolar and bipolar disorders were particular points of disagreement, with similar rates of under and over-diagnosis of bipolar disorder. The rate of confirmation of referring clinician diagnoses of schizoaffective disorder was 10 percent with the SCID and 11 percent with the MINI. Discussion. In this setting, there appears to be a reasonable trade-off between brevity and accuracy through the use of the MINI compared to the SCID, with substantial improvements in stability of diagnoses compared to clinician diagnoses. Clinical diagnoses were minimally overlapping with the results of structured diagnoses, suggesting that structured assessment, particularly early in the illness or in short term treatment settings, may improve treatment planning.

Entities:  

Keywords:  Bipolar disorder; psychosis; structured diagnoses; validity

Year:  2013        PMID: 23882436      PMCID: PMC3719455     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  19 in total

1.  Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis.

Authors:  J E Schwartz; S Fennig; M Tanenberg-Karant; G Carlson; T Craig; N Galambos; J Lavelle; E J Bromet
Journal:  Arch Gen Psychiatry       Date:  2000-06

Review 2.  Schizoaffective disorder--an ongoing challenge for psychiatric nosology.

Authors:  M Jäger; S Haack; T Becker; K Frasch
Journal:  Eur Psychiatry       Date:  2010-06-19       Impact factor: 5.361

3.  Long-term diagnostic stability and outcome in recent first-episode cohort studies of schizophrenia.

Authors:  Evelyn J Bromet; Bushra Naz; Laura J Fochtmann; Gabrielle A Carlson; Marsha Tanenberg-Karant
Journal:  Schizophr Bull       Date:  2005-06-23       Impact factor: 9.306

Review 4.  The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.

Authors:  Sean H Yutzy; Chad R Woofter; Christopher C Abbott; Imad M Melhem; Brooke S Parish
Journal:  J Nerv Ment Dis       Date:  2012-05       Impact factor: 2.254

Review 5.  Diagnosis of schizophrenia: consistency across information sources and stability of the condition.

Authors:  Philip D Harvey; Robert K Heaton; William T Carpenter; Michael F Green; James M Gold; Michael Schoenbaum
Journal:  Schizophr Res       Date:  2012-04-13       Impact factor: 4.939

6.  Diagnosis of manic episodes in adolescent inpatients: structured diagnostic procedures compared to clinical chart diagnoses.

Authors:  D L Pogge; D Wayland-Smith; M Zaccario; S Borgaro; J Stokes; P D Harvey
Journal:  Psychiatry Res       Date:  2001-02-14       Impact factor: 3.222

Review 7.  Clinical and economic effects of unrecognized or inadequately treated bipolar disorder.

Authors:  Paul E Keck; Ronald C Kessler; Ruth Ross
Journal:  J Psychiatr Pract       Date:  2008-05       Impact factor: 1.325

Review 8.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

Review 9.  Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease--there is no schizoaffective disorder.

Authors:  Charles Ray Lake; Nathaniel Hurwitz
Journal:  Curr Opin Psychiatry       Date:  2007-07       Impact factor: 4.741

Review 10.  Schizoaffective disorder: diagnostic issues and future recommendations.

Authors:  Gin S Malhi; Melissa Green; Andrea Fagiolini; Eric D Peselow; Veena Kumari
Journal:  Bipolar Disord       Date:  2008-02       Impact factor: 6.744

View more
  2 in total

1.  Measuring and Facilitating Client Engagement with Financial Incentives: Implications for Improving Clinical Outcomes in a Mental Health Setting.

Authors:  Raymond J Kotwicki; Alexandra M Balzer; Philip D Harvey
Journal:  Community Ment Health J       Date:  2016-09-26

2.  Effects of a right unilateral ultrabrief pulse electroconvulsive therapy course on health related quality of life in elderly depressed patients.

Authors:  W Vaughn McCall; Sarah H Lisanby; Peter B Rosenquist; Mary Dooley; Mustafa M Husain; Rebecca G Knapp; Georgios Petrides; Matthew V Rudorfer; Robert C Young; Shawn M McClintock; Martina Mueller; Joan Prudic; Robert M Greenberg; Richard D Weiner; Samuel H Bailine; Mary Anne Riley; Laryssa McCloud; Charles H Kellner
Journal:  J Affect Disord       Date:  2016-11-11       Impact factor: 4.839

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.